 | Date: Wednesday, February 13, 2019 Time: 12:00 - 14:00 Venue: Tokyo American Club, Brooklyn Room Speaker: Dr. BT Slingsby, founding CEO of the Global Health Innovative Technology Fund (GHIT) Hosting Committees: Healthcare, Digital Health, Medical Devices and Diagnostics, Pharmaceuticals, Regenerative Medicine and Bioscience Member Fee: ¥4,500 Guest Fee: ¥7,900 Meal: Plated Lunch Registration/Cancellation Deadline: Thursday, February 7, 2019 12:00 noon |
Event Overview:
Dr. BT Slingsby will give his insights, experiences, and lessons learned as a catalyst for public private partnership (PPP) and external R&D, and provide a view on how this model can be applied to other areas where there is a need of new innovations.
Dr. Slingsby is a founding CEO of the Global Health Innovative Technology Fund (GHIT), the world's first PPP fund for global health R&D. GHIT was established in 2013 as an international PPP between Japanese pharmaceutical companies, the Bill and Melinda Gates Foundation, and two Japanese ministries.
GHIT’s innovative financing model was conceived and institutionalized by the private sector’s leadership, and GHIT has catalyzed open innovation between Japanese and global entities to create life saving medicines through its investment. Utilizing not only internal but also external R&D resources is becoming an increasingly significant trend in pharmaceutical industry to drive innovations.
John W. Carlson III, Chair
William Bishop, Yuko Kidoguchi, Takeo Morooka, Toshio Nagase, R. Byron Sigel, Mika Shirai, Vice Chairs
ACCJ Healthcare Committee
Eiji Sasahara, Chair
Seiji Inada, Marc Fuoti, Vice Chairs
ACCJ Digital Health Subcommittee
William Bishop, Chair
Marie Kissel, Yasuhiko Amano, Jun Sekiguchi, Vice Chairs
ACCJ Medical Devices and Diagnostics Subcommittee
Takeo Morooka, Chair
ACCJ Pharmaceuticals Subcommittee
Yaju Hiromichi, Chair
Satoshi Tanaka, Vice Chair
ACCJ Regenerative Medicine and Bioscience Subcommittee
NOTE 1: This event is OFF THE RECORD.
NOTE 2: If you cancel after the stated deadline, the full meeting fee will be charged to your account. All guests must be accompanied by an ACCJ member. Sorry, no substitutions or walk-ins.
NOTE 3: If you are driving to the Tokyo American Club, please inform the ACCJ of the make, model, color and plate of the vehicle, by the registration deadline, as arrangements must be made. A 1,700 yen parking fee will apply.
NOTE 4: 500 yen of each participant's attendance fee will be deposited into the Healthcare Committee Fund.
Dr. BT Slingsby will give his insights, experiences, and lessons learned as a catalyst for public private partnership (PPP) and external R&D, and provide a view on how this model can be applied to other areas where there is a need of new innovations.
Dr. Slingsby is a founding CEO of the Global Health Innovative Technology Fund (GHIT), the world's first PPP fund for global health R&D. GHIT was established in 2013 as an international PPP between Japanese pharmaceutical companies, the Bill and Melinda Gates Foundation, and two Japanese ministries.
GHIT’s innovative financing model was conceived and institutionalized by the private sector’s leadership, and GHIT has catalyzed open innovation between Japanese and global entities to create life saving medicines through its investment. Utilizing not only internal but also external R&D resources is becoming an increasingly significant trend in pharmaceutical industry to drive innovations.
John W. Carlson III, Chair
William Bishop, Yuko Kidoguchi, Takeo Morooka, Toshio Nagase, R. Byron Sigel, Mika Shirai, Vice Chairs
ACCJ Healthcare Committee
Eiji Sasahara, Chair
Seiji Inada, Marc Fuoti, Vice Chairs
ACCJ Digital Health Subcommittee
William Bishop, Chair
Marie Kissel, Yasuhiko Amano, Jun Sekiguchi, Vice Chairs
ACCJ Medical Devices and Diagnostics Subcommittee
Takeo Morooka, Chair
ACCJ Pharmaceuticals Subcommittee
Yaju Hiromichi, Chair
Satoshi Tanaka, Vice Chair
ACCJ Regenerative Medicine and Bioscience Subcommittee
NOTE 1: This event is OFF THE RECORD.
NOTE 2: If you cancel after the stated deadline, the full meeting fee will be charged to your account. All guests must be accompanied by an ACCJ member. Sorry, no substitutions or walk-ins.
NOTE 3: If you are driving to the Tokyo American Club, please inform the ACCJ of the make, model, color and plate of the vehicle, by the registration deadline, as arrangements must be made. A 1,700 yen parking fee will apply.
NOTE 4: 500 yen of each participant's attendance fee will be deposited into the Healthcare Committee Fund.
